Form 4: Immuneering Corp Director Peter Feinberg Acquires Stock Options

Director Peter Feinberg acquired stock options in Immuneering Corp in lieu of cash compensation.

Summary

• Peter Feinberg, a director of Immuneering Corp, filed a Form 4 indicating a change in beneficial ownership.
• The transaction involved the acquisition of stock options in lieu of receiving cash compensation under the company's Non-Employee Director Compensation Program.
• Feinberg acquired 23,485 stock options with an exercise price of $2.20 on January 1, 2025.
• The options vest in quarterly installments over one year, contingent upon continuous service as a Non-Employee Director, with final vesting on the first anniversary of the grant date.
• Following the transaction, Feinberg directly owns 23,485 derivative securities.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects a standard compensation practice that aligns director interests with shareholder value. There are no indications of negative news or concerns.

Positives

• The acquisition of stock options aligns the director's interests with those of the shareholders.
• The vesting schedule incentivizes continued service and commitment to the company.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

This filing is a routine disclosure related to director compensation and is common in publicly traded companies. It reflects a standard practice of using stock options to incentivize and align the interests of non-employee directors with the company's long-term performance.

Comparison to Industry Standards

• Granting stock options to non-employee directors is a common practice among publicly traded companies, particularly in the biotech industry.
• Companies like Amgen, Gilead Sciences, and Biogen also utilize stock options as part of their director compensation packages.
• The vesting schedules and exercise prices are typically structured to align with industry norms and incentivize long-term value creation.

Stakeholder Impact

• The granting of stock options to a director can positively impact shareholders by aligning the director's interests with the company's long-term success.
• Employees may view this as a positive sign of the company's commitment to its leadership.

Key Dates